Hims & Hers Spikes; Will The FDA Blow The Door Open On Peptide Compounding?Investors Business Daily • 04/16/26
Hims & Hers Health Stock Rallies on Regulatory Pivot. It's Not About GLP-1s This Time.Barrons • 04/16/26
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptidesMarket Watch • 04/15/26
Hims & Hers Powers Patient-Provider Connectivity via Digital PlatformsZacks Investment Research • 04/14/26
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law FirmGlobeNewsWire • 04/08/26
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key FactsZacks Investment Research • 04/07/26
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data BreachGlobeNewsWire • 04/03/26
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMSBusiness Wire • 04/03/26
Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 03/30/26
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now?Zacks Investment Research • 03/25/26